Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02865447 · ClinicalTrials.gov registry record
Evaluation of Bone Mineral Density Changes After Total Hip Replacement: A Two-Year Clinical and DXA Analysis
A clinical trial, sponsored by MicroPort Orthopedics.
- Completed
- Registry status
- 25
- Enrollment target
NCT02865447: Completed study, sponsored by MicroPort Orthopedics.
NCT02865447 is a clinical trial that has completed, run by MicroPort Orthopedics. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02865447 has completed, sponsored by MicroPort Orthopedics.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
Sponsor is conducting this post-market study to evaluate the clinical outcome and femoral bone mineral density (BMD) changes associated with the PROFEMUR® PRESERVE hip stem when used as indicated for primary total hip arthroplasty in patients with osteoarthritis of the hip joint.
Interventions
- DEVICE total hip arthroplasty implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2017-03-09 |
| Est. Completion | 2020-08-24 |
What the finished NCT02865447 record still lists
NCT02865447 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which total hip arthroplasty implant is the first listed.
NCT02865447 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02865447 about?
NCT02865447 is a clinical study titled "Evaluation of Bone Mineral Density Changes After Total Hip Replacement: A Two-Year Clinical and DXA Analysis". Sponsor is conducting this post-market study to evaluate the clinical outcome and femoral bone mineral density (BMD) changes associated with the PROFEMUR® PRESERVE hip stem when used as indicated for primary total hip arthroplasty in patients with osteoarthritis of the hip joint.
What is the current status of trial NCT02865447?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2017-03-09. Estimated completion is 2020-08-24.
What interventions are being tested in trial NCT02865447?
The interventions under investigation include: total hip arthroplasty implant (DEVICE).
Who is sponsoring clinical trial NCT02865447?
This trial is sponsored by MicroPort Orthopedics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI